Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus

B Mookerjee, V Altomonte, G Vogelsang - Bone marrow transplantation, 1999 - nature.com
Chronic graft-versus-host disease (GVHD) is a common late complication of allogeneic bone
marrow transplantation (BMT) and is the principal cause of morbidity and non-relapse …
被引用次数：153 相关文章

Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus

B Mookerjee, V Altomonte… - Bone marrow …, 1999 - pure.johnshopkins.edu
Chronic graft-versus-host disease (GVHD) is a common late complication of allogeneic bone
marrow transplantation (BMT) and is the principal cause of morbidity and non-relapse …

Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus

B Mookerjee, V Altomonte… - Bone marrow …, 1999 - jhu.pure.elsevier.com
Chronic graft-versus-host disease (GVHD) is a common late complication of allogeneic bone
marrow transplantation (BMT) and is the principal cause of morbidity and non-relapse …

Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus

B Mookerjee, V Altomonte… - Bone marrow …, 1999 - pubmed.ncbi.nlm.nih.gov
Chronic graft-versus-host disease (GVHD) is a common late complication of allogeneic bone
marrow transplantation (BMT) and is the principal cause of morbidity and non-relapse …

Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus.

B Mookerjee, V Altomonte… - Bone Marrow …, 1999 - europepmc.org
Chronic graft-versus-host disease (GVHD) is a common late complication of allogeneic bone
marrow transplantation (BMT) and is the principal cause of morbidity and non-relapse …

[引用][C] Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus

B MOOKERJEE, V ALTOMONTE… - Bone marrow …, 1999 - pascal-francis.inist.fr
Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil
and tacrolimus CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus.

B Mookerjee, V Altomonte… - Bone Marrow …, 1999 - search.ebscohost.com
Chronic graft-versus-host disease (GVHD) is a common late complication of allogeneic bone
marrow transplantation (BMT) and is the principal cause of morbidity and non-relapse …

[引用][C] Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus

B Mookerjee, V Altomonte, G Vogelsang - Bone Marrow Transplantation, 1999 - cir.nii.ac.jp
Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil
and tacrolimus | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

[引用][C] Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus

B MOOKERJEE - Bone Marrow Transplant, 1999 - cir.nii.ac.jp

[引用][C] Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus

B MOOKERJEE, V ALTOMONTE… - Bone marrow …, 1999 - Nature Publishing Group